SCHEMBL9107772

SCHEMBL9107772

Cc1ccc(N/N=C2\C(=O)C(C(=O)[O-])=Cc3ccccc32)c(S(=O)(=O)[O-])c1.[Ba+2]

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY4 P51582 6/20 0.36
P2RY2 P41231 5/20 0.36
CDK2 P24941 1/20 0.35
MAPT P10636 6/20 0.33
ALDH1A1 P00352 5/20 0.33
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
GAA P10253 2/20 0.33
KMT2A Q03164 6/20 0.33
MEN1 O00255 5/20 0.33
P2RY12 Q9H244 3/20 0.32
P2RY6 Q15077 1/20 0.32
TDP1 Q9NUW8 4/20 0.32
MAPK1 P28482 3/20 0.32
HTT P42858 2/20 0.32
POLB P06746 3/20 0.31
NSD2 O96028 2/20 0.31
THRB P10828 2/20 0.31
HPGD P15428 2/20 0.31
RECQL P46063 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL341670 0.98 P2RY4 (0.36) P2RY4P2RY2CDK2MAPTALDH1A1
SCHEMBL341437 0.98 P2RY4 (0.38) P2RY4P2RY2CDK2MAPTALDH1A1
SCHEMBL21436560 0.97 P2RY4 (0.36) P2RY4P2RY2CDK2MAPTALDH1A1
SCHEMBL571587 0.85 P2RY4 (0.35) P2RY4P2RY2CDK2MAPTALDH1A1
SCHEMBL21436616 0.83 P2RY4 (0.35) P2RY4P2RY2CDK2MAPTALDH1A1
SCHEMBL21436773 0.83 P2RY4 (0.35) P2RY4P2RY2CDK2MAPTALDH1A1
SCHEMBL21436337 0.83 P2RY4 (0.37) P2RY4P2RY2CDK2MAPTALDH1A1
SCHEMBL375654 0.83 P2RY4 (0.35) P2RY4P2RY2CDK2MAPTALDH1A1
SCHEMBL341149 0.83 P2RY4 (0.37) P2RY4P2RY2CDK2MAPTALDH1A1
SCHEMBL10087038 0.82 LMNA (0.38) MAPTALDH1A1RAB9ANPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3086762-B1 ORAL CARE COMPOSITIONS WITH REDUCED SURFACE STAINING COLGATE PALMOLIVE CO (US) 2019-08-28 EP claimed
EP-3323469-A1 COLOURING COMPOSITIONS J Colors S.p.A. (IT) 2018-05-23 EP claimed
US-20160324753-A1 ORAL CARE COMPOSITIONS WITH REDUCED SURFACE STAINING COLGATE-PALMOLIVE COMPANY (US) 2016-11-10 US claimed
US-20250108658-A1 INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS Prism Inks, Inc. (US) 2025-04-03 US disclosed
US-20230310300-A1 HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER HFC PRESTIGE SERVICE GERMINY GMBH (DE) 2023-10-05 US disclosed
EP-4171500-A1 HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER Wella Germany GmbH (DE) 2023-05-03 EP disclosed
US-11324688-B2 Bicomponent composition WELLA INTERNATIONAL OPERATIONS SWI (CH) 2022-05-10 US disclosed
US-20220054392-A1 MULTICOMPONENT IN SITU COLORATION COMPOSITION WELLA INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2022-02-24 US disclosed
US-20220016017-A1 COLOR COATINGS WITH DOWNSTREAM FEATURES HFC PRESTIGE SERVICE GERMANY GMBH (DE) 2022-01-20 US disclosed
WO-2022002983-A1 HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER HFC PRESTIGE SERVICE GERMANY GMBH (DE) 2022-01-06 WO disclosed
EP-3890683-A1 MULTICOMPONENT IN SITU COLORATION COMPOSITION HFC Prestige International Holding Switzerland S.a.r.l. (CH) 2021-10-13 EP disclosed
WO-2020007510-A1 MULTICOMPONENT PUR COMPOSITION HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2020-01-09 WO disclosed
WO-2019192916-A1 BICOMPONENT COMPOSITION HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2019-10-10 WO disclosed
EP-3086762-B1 ORAL CARE COMPOSITIONS WITH REDUCED SURFACE STAINING COLGATE PALMOLIVE CO (US) 2019-08-28 EP disclosed
CN-105828785-B The oral care composition of surface contamination with reduction 高露洁-棕榄公司 2019-05-03 CN disclosed
EP-3323469-A1 COLOURING COMPOSITIONS J Colors S.p.A. (IT) 2018-05-23 EP disclosed
US-20160324753-A1 ORAL CARE COMPOSITIONS WITH REDUCED SURFACE STAINING COLGATE-PALMOLIVE COMPANY (US) 2016-11-10 US disclosed
EP-3086762-A1 ORAL CARE COMPOSITIONS WITH REDUCED SURFACE STAINING Colgate-Palmolive Company (US) 2016-11-02 EP disclosed
WO-2015100010-A1 ORAL CARE COMPOSITIONS WITH REDUCED SURFACE STAINING COLGATE-PALMOLIVE COMPANY (US) 2015-07-02 WO disclosed
US-20120141398-A1 HAIR DYE CONTAINING ONE OR MORE EDIBLE OR COSMETIC COLORS CHUANG KUO SHENG (TW) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220016017-A1 COLOR COATINGS WITH DOWNSTREAM FEATURES KRT18, ITGA5, FLNA P2RY4 3803/4885P2RY2 3753/4885CDK2 1339/4885
US-20230310300-A1 HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER KRT18, MKI67, IK P2RY4 4027/4885P2RY2 4412/4885CDK2 1052/4885
US-20220054392-A1 MULTICOMPONENT IN SITU COLORATION COMPOSITION KRT18, PRKDC, VIM P2RY4 4672/4885P2RY2 4696/4885CDK2 1016/4885
US-11324688-B2 Bicomponent composition KRT18, EXOSC10, EXOSC9 P2RY4 3269/4885P2RY2 2950/4885CDK2 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.